The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and ...
But the court ruled another similar patent was valid and that Pfizer and BioNTech’s Comirnaty vaccine had infringed it, ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal. In July, a High Court judge delivered a mixed ...
In July, a High Court judge delivered a mixed ruling in the long-running dispute that has pitted pharmaceutical giant Pfizer Inc and German drug manufacturer BioNTech SE, against Cambridge, ...
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
The Canadian Press on MSN2d
Health Canada approves Pfizer-BioNTech's updated COVID-19 vaccinePfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and olderData demonstrate that the Omicron KP.2-adapted COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback